{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:03:43Z","timestamp":1790813023947,"version":"4.1.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>With increasing prevalence, chronic kidney disease (CKD) has become a global health problem. Due to the retention of uremic toxins, electrolytes and water, and the resultant metabolic disturbances, CKD affects several organs, including the nervous system. Thus, CKD patients suffer from several neurological complications, including dementia, cognitive impairment, motor abnormalities, depression, and mood and sleep disturbances. However, the mechanisms underlying the neurological complications are least elucidated. We have recently reported a highly reproducible mice model of CKD induced by high adenine diet, which exhibited psychomotor behavioral abnormalities and blood-brain barrier disruption. In the present study, using the mice model, we have investigated psycho-motor and cognitive behaviour, and the neurochemical and histopathological alterations in brain relevant to the observed behavioural abnormalities. The results demonstrate global loss of Acetylcholinesterase activity, and decrease in neuronal arborisation and dendritic spine density in discrete brain regions, of the CKD mice. Oxidative stress, inflammation, and mitochondrial dysfunctions were found in specific brain regions of the mice, which have been regarded as the underlying causes of the observed neurochemical and histopathological alterations. Thus, the present study is of immense importance, and has therapeutic implications in the management of CKD-associated neurological complications.<\/jats:p>","DOI":"10.1038\/s41598-018-37935-3","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T11:05:03Z","timestamp":1551351903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Neurological sequel of chronic kidney disease: From diminished Acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain"],"prefix":"10.1038","volume":"9","author":[{"given":"Muhammed Khairujjaman","family":"Mazumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajib","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallab","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupom","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"37935_CR1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey, A. S. et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67, 2089\u20132100 (2005).","journal-title":"Kidney Int."},{"key":"37935_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey, A. S. et al. The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 80, 17\u201328 (2011).","journal-title":"Kidney Int."},{"key":"37935_CR3","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/01.ASN.0000070152.11927.4A","volume":"14","author":"SJ Chadban","year":"2003","unstructured":"Chadban, S. J. et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J. Am. Soc. Nephrol. 14, S131\u2013138 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"37935_CR4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1681\/ASN.2005060627","volume":"17","author":"CS Fox","year":"2006","unstructured":"Fox, C. S. et al. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J. Am. Soc. Nephrol. 17, 521\u2013527 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"37935_CR5","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1046\/j.1523-1755.63.s83.24.x","volume":"83","author":"V Sakhuja","year":"2003","unstructured":"Sakhuja, V. & Sud, K. End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int. 83, S115\u2013118 (2003).","journal-title":"Kidney Int."},{"key":"37935_CR6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1081\/JDI-120039516","volume":"26","author":"V Jha","year":"2004","unstructured":"Jha, V. End-stage renal care in developing countries: the India experience. Ren. Fail. 26, 201\u2013208 (2004).","journal-title":"Ren. Fail."},{"key":"37935_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ckj\/sfv109","volume":"9","author":"G Abraham","year":"2016","unstructured":"Abraham, G. et al. Chronic kidney disease hotspots in developing countries in South Asia. Clin. Kidney J. 9, 135\u2013141 (2016).","journal-title":"Clin. Kidney J."},{"key":"37935_CR8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1525-1497.2002.20634.x","volume":"17","author":"AT Kausz","year":"2002","unstructured":"Kausz, A. T. & Levey, A. S. The care of patients with chronic kidney disease. J. Gen. Intern. Med. 17, 658\u2013662 (2002).","journal-title":"J. Gen. Intern. Med."},{"key":"37935_CR9","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2011.11.015","volume":"59","author":"AJ Collins","year":"2012","unstructured":"Collins, A. J. et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am. J. Kidney Dis. 59, A7, https:\/\/doi.org\/10.1053\/j.ajkd.2011.11.015 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"37935_CR10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(97)09411-7","volume":"353","author":"NP Mallick","year":"1999","unstructured":"Mallick, N. P. & Gokal, R. Haemodialysis. Lancet 353, 737\u2013742 (1999).","journal-title":"Lancet"},{"key":"37935_CR11","first-page":"426","volume":"37","author":"SC Hung","year":"2001","unstructured":"Hung, S. C., Hung, S. H., Tarng, D. C., Yang, W. C. & Huang, T. P. Chorea induced by thiamine deficiency in hemodialysis patients. Am. J. Kidney Dis. 37, 426\u2013430 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"37935_CR12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrneph.2010.37","volume":"6","author":"F Fabrizi","year":"2010","unstructured":"Fabrizi, F., Messa, P., Basile, C. & Martin, P. Hepatic disorders in chronic kidney disease. Nat. Rev. Nephrol. 6, 395\u2013403 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"37935_CR13","first-page":"170","volume":"23","author":"P Jungers","year":"1997","unstructured":"Jungers, P. et al. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner. Electrolyte Metab. 23, 170\u2013173 (1997).","journal-title":"Miner. Electrolyte Metab."},{"key":"37935_CR14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ndt\/gfk021","volume":"21","author":"D Nitsch","year":"2006","unstructured":"Nitsch, D. et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol. Dial. Transplant 21, 935\u2013944 (2006).","journal-title":"Nephrol. Dial. Transplant"},{"key":"37935_CR15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1523-1755.2005.00397.x","volume":"68","author":"T Ninomiya","year":"2005","unstructured":"Ninomiya, T. et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 68, 228\u2013236 (2005).","journal-title":"Kidney Int."},{"key":"37935_CR16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrneurol.2009.138","volume":"5","author":"AV Krishnan","year":"2009","unstructured":"Krishnan, A. V. & Kiernan, M. C. Neurological complications of chronic kidney disease. Nat. Rev. Neurol. 5, 542\u2013551 (2009).","journal-title":"Nat. Rev. Neurol."},{"key":"37935_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.ackd.2008.01.010","volume":"15","author":"AM Murray","year":"2008","unstructured":"Murray, A. M. Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden. Adv. Chronic Kid. Dis. 15, 123\u2013132 (2008).","journal-title":"Adv. Chronic Kid. Dis."},{"key":"37935_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-139X.2008.00555.x","volume":"22","author":"AV Krishnan","year":"2009","unstructured":"Krishnan, A. V., Pussell, B. A. & Kiernan, M. C. Neuromuscular disease in the dialysis patient: an update for the nephrologist. Semin. Dial. 22, 267\u2013278 (2009).","journal-title":"Semin. Dial."},{"key":"37935_CR19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1525-139X.2005.18209.x","volume":"18","author":"PL Kimmel","year":"2005","unstructured":"Kimmel, P. L. & Peterson, R. A. Depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs. Semin. Dial. 18, 91\u201397 (2005).","journal-title":"Semin. Dial."},{"key":"37935_CR20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/ndt\/gfh654","volume":"20","author":"I Mucsi","year":"2005","unstructured":"Mucsi, I. et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol. Dial. Transplant 20, 571\u2013577 (2005).","journal-title":"Nephrol. Dial. Transplant"},{"key":"37935_CR21","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1097\/01.ASN.0000131529.60019.FA","volume":"15","author":"SL Seliger","year":"2004","unstructured":"Seliger, S. L. et al. Moderate renal impairment and risk of dementia among older adults: The cardiovascular health cognition study. J. Am. Soc. Nephrol. 15, 1904\u20131911 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"37935_CR22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00467-006-0269-1","volume":"22","author":"DS Gipson","year":"2007","unstructured":"Gipson, D. S., Duquette, P. J., Icard, P. F. & Hooper, S. R. The central nervous system in childhood chronic kidney disease. Pediatr. Nephrol. 22, 1703\u20131710 (2007).","journal-title":"Pediatr. Nephrol."},{"key":"37935_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lfs.2016.07.020","volume":"161","author":"MK Mazumder","year":"2016","unstructured":"Mazumder, M. K., Giri, A., Kumar, S. & Borah, A. A highly reproducible mice model of chronic kidney disease: Evidences of behavioural abnormalities and blood-brain barrier disruption. Life Sci. 161, 27\u201336 (2016).","journal-title":"Life Sci."},{"key":"37935_CR24","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1681\/ASN.2005010005","volume":"16","author":"M Kurella","year":"2005","unstructured":"Kurella, M. et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J. Am. Soc. Nephrol. 16, 2127\u20132133 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"37935_CR25","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1532-5415.2004.52508.x","volume":"52","author":"M Kurella","year":"2004","unstructured":"Kurella, M., Chertow, G. M., Luan, J. & Yaffe, K. Cognitive impairment in chronic kidney disease. J. Am. Geriatr. Soc. 52, 1863\u20131869 (2004).","journal-title":"J. Am. Geriatr. Soc."},{"key":"37935_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","volume":"68","author":"DS Auld","year":"2002","unstructured":"Auld, D. S., Kornecook, T. J., Bastianetto, S. & Quirion, R. Alzheimer\u2019s disease and the basal forebrain cholinergic system: relations to [beta]-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 68, 209\u2013245 (2002).","journal-title":"Prog. Neurobiol."},{"key":"37935_CR27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2005.01.031","volume":"380","author":"NI Bohnen","year":"2005","unstructured":"Bohnen, N. I. et al. Cognitive correlates of alterations in acetylcholinesterase in Alzheimer\u2019s disease. Neurosci. Letters 380, 127\u2013132 (2005).","journal-title":"Neurosci. Letters"},{"key":"37935_CR28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1531-8257(199901)14:1<102::AID-MDS1017>3.0.CO;2-E","volume":"14","author":"C Trenkwalder","year":"1999","unstructured":"Trenkwalder, C. et al. Circadian rhythm of periodic limb movements and sensory symptoms of restless leg syndrome. Mov. Disorders 14, 102\u2013110 (1999).","journal-title":"Mov. Disorders"},{"key":"37935_CR29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.clineuro.2005.04.002","volume":"108","author":"C Cupidi","year":"2006","unstructured":"Cupidi, C., Piccoli, F. & La Bella, V. Acute reversible parkinsonism in a diabetic-uremic patient. Clin. Neurol. Neurosurg. 108, 601\u2013603 (2006).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"37935_CR30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/sleep\/18.8.681","volume":"18","author":"C Trenkwalder","year":"1995","unstructured":"Trenkwalder, C. et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 18, 681\u2013688 (1995).","journal-title":"Sleep"},{"key":"37935_CR31","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1681\/ASN.2007080901","volume":"19","author":"M Liu","year":"2008","unstructured":"Liu, M. et al. Acute kidney injury leads to inflammation and functional changes in the brain. J. Am. Soc. Nephrol. 19, 1360\u20131370 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"37935_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17911-z","volume":"7","author":"R Paul","year":"2017","unstructured":"Paul, R. & Borah, A. Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice. Sci. Rep. 7, 17922, https:\/\/doi.org\/10.1038\/s41598-017-17911-z (2017).","journal-title":"Sci. Rep."},{"key":"37935_CR33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jcp.13.2.156","volume":"13","author":"JK Fawcett","year":"1960","unstructured":"Fawcett, J. K. & Scott, J. E. A rapid and precise method for the determination of urea. J. Chin. Path. 13, 156\u2013159 (1960).","journal-title":"J. Chin. Path."},{"key":"37935_CR34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0021-9258(19)51334-5","volume":"158","author":"RW Bonsnes","year":"1945","unstructured":"Bonsnes, R. W. & Taussky, H. H. On the colorimetric determination of creatinine by the Jaffe reaction. J. Biol. Chem. 158, 581\u2013591 (1945).","journal-title":"J. Biol. Chem."},{"key":"37935_CR35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/clinchem\/26.2.227","volume":"26","author":"P Fossati","year":"1980","unstructured":"Fossati, P., Prencipe, L. & Berti, G. Use of 3, 5-Dichloro- 2-hydroxybenzenesulfonic Acid\/4-Aminophenazone Chromogenic System in Direct Enzymic Assay of Uric Acid in Serum and Urine. Clin. Chem. 26, 227\u2013231 (1980).","journal-title":"Clin. Chem."},{"key":"37935_CR36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman, G. L., Courtney, K. D., Andres, V. Jr. & Feather-Stone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88\u201395 (1961).","journal-title":"Biochem. Pharmacol."},{"key":"37935_CR37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuint.2017.01.021","volume":"108","author":"R Paul","year":"2017","unstructured":"Paul, R. et al. Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson\u2019s disease. Neurochem. Int. 108, 15\u201326 (2017).","journal-title":"Neurochem. Int."},{"key":"37935_CR38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2014.01.048","volume":"264","author":"J Chakraborty","year":"2014","unstructured":"Chakraborty, J., Nthenge-Ngumbau, D. N., Rajamma, U. & Mohanakumar, K. P. Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. Behav. Brain Res. 264, 91\u2013104 (2014).","journal-title":"Behav. Brain Res."},{"key":"37935_CR39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04996.x","volume":"104","author":"M Pandey","year":"2008","unstructured":"Pandey, M. et al. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. J. Neurochem. 104, 420\u2013434 (2008).","journal-title":"J. Neurochem."},{"key":"37935_CR40","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1523\/JNEUROSCI.12-09-03509.1992","volume":"12","author":"D Riddle","year":"1992","unstructured":"Riddle, D., Richards, A., Zsuppan, F. & Purves, D. Growth of the rat somatic sensory cortex and its constituent parts during postnatal development. J. Neurosci. 12, 3509\u20133524 (1992).","journal-title":"J. Neurosci."},{"key":"37935_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-3806(00)00092-4","volume":"124","author":"Govindaiah","year":"2000","unstructured":"Govindaiah et al. Cytochrome oxidase activity in rat retinal ganglion cells during postnatal development. Brain Res. Dev. Brain Res. 124, 117\u2013120 (2000).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"37935_CR42","doi-asserted-by":"publisher","first-page":"e0171285","DOI":"10.1371\/journal.pone.0171285","volume":"12","author":"R Paul","year":"2017","unstructured":"Paul, R. et al. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson\u2019s disease: Involvement of mitochondrial dysfunctions and oxidative stress. PLoS ONE 12, e0171285, https:\/\/doi.org\/10.1371\/journal.pone.0171285 (2017).","journal-title":"PLoS ONE"},{"key":"37935_CR43","first-page":"169","volume":"43","author":"J Koudelov\u00e1","year":"1994","unstructured":"Koudelov\u00e1, J. & Mourek, J. The lipid peroxidation in various parts of the rat brain: effect of age, hypoxia and hyperoxia. Physiol. Res. 43, 169\u2013173 (1994).","journal-title":"Physiol. Res."},{"key":"37935_CR44","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1073\/pnas.88.7.2811","volume":"88","author":"BT Hope","year":"1991","unstructured":"Hope, B. T., Michael, G. J., Knigge, K. M. & Vincent, S. R. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. USA 88, 2811\u20132814 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37935_CR45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H. et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."},{"key":"37935_CR46","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"37935_CR47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ki.2011.198","volume":"80","author":"RG Fassett","year":"2011","unstructured":"Fassett, R. G. et al. Biomarkers in chronic kidney disease: a review. Kidney Int. 80, 806\u2013821 (2011).","journal-title":"Kidney Int."},{"key":"37935_CR48","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder, R. et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 63, 1934\u20131943 (2003).","journal-title":"Kidney Int."},{"key":"37935_CR49","first-page":"371","volume":"27","author":"T Yokozawa","year":"1985","unstructured":"Yokozawa, T., Oura, H. & Koizumi, F. 2,8-dihydroxyadenine urolithiasis induced by dietary adenine in rats. Nihon. Jinzo. Gakkai. Shi. 27, 371\u2013378 (1985).","journal-title":"Nihon. Jinzo. Gakkai. Shi."},{"key":"37935_CR50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000183992","volume":"44","author":"T Yokozawa","year":"1986","unstructured":"Yokozawa, T., Zheng, P. D., Oura, H. & Koizumi, F. Animal model of adenine-induced chronic renal failure in rats. Nephron 44, 230\u2013234 (1986).","journal-title":"Nephron"},{"key":"37935_CR51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1797.2009.01161.x","volume":"15","author":"R Ikeda","year":"2010","unstructured":"Ikeda, R., Imai, Y., Maruyama, W. & Mizoguchi, K. Systemic disorders of calcium dynamics in rats with adenine-induced renal failure: implication for chronic kidney disease-related complications. Nephrology (Carlton) 15, 54\u201362 (2010).","journal-title":"Nephrology (Carlton)"},{"key":"37935_CR52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1258\/ebm.2010.010163","volume":"236","author":"BH Ali","year":"2011","unstructured":"Ali, B. H., Ziada, A., Al-Husseni, I., Beegam, S. & Nemmar, A. Motor and behavioural changes in rats with adenine-induced chronic renal failure: Influence of acacia gum treatment. Exp. Biol. Med. (Maywood) 236, 107\u2013112 (2011).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"37935_CR53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2369-14-116","volume":"14","author":"T Jia","year":"2013","unstructured":"Jia, T. et al. A novel model of adenine-induced tubulointerstitial nephropathy in mice. BMC Nephrol. 14, 116 (2013).","journal-title":"BMC Nephrol."},{"key":"37935_CR54","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ki.2008.700","volume":"75","author":"I Matsui","year":"2009","unstructured":"Matsui, I. et al. Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int. 75, 915\u2013928 (2009).","journal-title":"Kidney Int."},{"issue":"10","key":"37935_CR55","first-page":"2341","volume":"41","author":"T Yokozawa","year":"1983","unstructured":"Yokozawa, T., Zheng, P. D. & Oura, H. Experimental Renal Failure Rats Induced by Adenine-Evaluation of Free Amino Acid, Ammonia Nitrogen and Guanidino Compound Levels. Agric. Biol. Chem. 41(10), 2341\u20132348 (1983).","journal-title":"Agric. Biol. Chem."},{"key":"37935_CR56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.phrs.2013.11.007","volume":"79","author":"V Diwan","year":"2014","unstructured":"Diwan, V., Gobe, G. & Brown, L. Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease. Pharmacol. Res. 79, 104\u2013110 (2014).","journal-title":"Pharmacol. Res."},{"key":"37935_CR57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1271\/nogeikagaku1924.56.655","volume":"56","author":"T Yokozawa","year":"1982","unstructured":"Yokozawa, T., Oura, H., Nakagawa, H. & Okada, T. Adenine-induced hyperuricemia and renal damage in rats. Nippon N\u020fgeikagaku Kaishi. 56, 655\u2013663 (1982).","journal-title":"Nippon N\u020fgeikagaku Kaishi."},{"key":"37935_CR58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vascn.2013.05.006","volume":"68","author":"V Diwan","year":"2013","unstructured":"Diwan, V., Mistry, A., Gobe, G. & Brown, L. Adenine-induced chronic kidney ad cardiovascular damage in rats. J. Pharmacol. Toxicol. Methods 68, 197\u2013207 (2013).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"37935_CR59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.33549\/physiolres.932685","volume":"63","author":"BH Ali","year":"2014","unstructured":"Ali, B. H., Al-Za\u2019abi, M., Ramkumar, A., Yasin, J. & Nemmar, A. Anemia in Adenine-induced Chronic Renal Failure and the influence of treatment with Gum Acacia thereon. Physiol. Res. 63, 351\u2013358 (2014).","journal-title":"Physiol. Res."},{"key":"37935_CR60","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/ndt\/gfs569","volume":"28","author":"AC Santana","year":"2013","unstructured":"Santana, A. C. et al. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice. Nephrol. Dial. Transplant 28, 1140\u20131149 (2013).","journal-title":"Nephrol. Dial. Transplant"},{"key":"37935_CR61","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.vascn.2013.05.001","volume":"68","author":"BH Ali","year":"2013","unstructured":"Ali, B. H. et al. New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats. J. Pharmacol. Toxicol. Methods 68, 384\u2013393 (2013).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"37935_CR62","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.phymed.2011.03.005","volume":"18","author":"BH Ali","year":"2011","unstructured":"Ali, B. H. et al. Effect of Acacia gum on blood pressure in rats with adenine-induced chronic renal failure. Phytomedicine 18, 1176\u20131180 (2011).","journal-title":"Phytomedicine"},{"key":"37935_CR63","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3892\/mmr.2013.1715","volume":"8","author":"Y Huang","year":"2013","unstructured":"Huang, Y. et al. Rosiglitazone alleviates injury in rats with adenine-induced chronic kidney disease. Mol. Med. Reports 8, 1831\u20131835 (2013).","journal-title":"Mol. Med. Reports"},{"key":"37935_CR64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787\u2013795 (2006).","journal-title":"Nature"},{"key":"37935_CR65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.lfs.2017.11.016","volume":"192","author":"R Paul","year":"2018","unstructured":"Paul, R. et al. Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson\u2019s disease. Life Sci. 192, 238\u2013245 (2018).","journal-title":"Life Sci."},{"key":"37935_CR66","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1073\/pnas.92.16.7162","volume":"92","author":"E Bonfoco","year":"1995","unstructured":"Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. & Lipton, S. A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide\/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92, 7162\u20137166 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37935_CR67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol, E. M. & Pekny, M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr. Opin. Cell Biol. 32, 121\u2013130 (2015).","journal-title":"Curr. Opin. Cell Biol."},{"key":"37935_CR68","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tins.2006.07.006","volume":"29","author":"F Zipp","year":"2006","unstructured":"Zipp, F. & Aktas, O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 29, 518\u2013527 (2006).","journal-title":"Trends Neurosci."},{"key":"37935_CR69","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0891-5849(98)00293-7","volume":"26","author":"RA Floyd","year":"1999","unstructured":"Floyd, R. A. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 26, 1346\u20131355 (1999).","journal-title":"Free Radic. Biol. Med."},{"key":"37935_CR70","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1523\/JNEUROSCI.21-17-06480.2001","volume":"21","author":"A Bal-Price","year":"2001","unstructured":"Bal-Price, A. & Brown, G. C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21, 6480\u20136491 (2001).","journal-title":"J. Neurosci."},{"key":"37935_CR71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","volume":"29","author":"MY Sherman","year":"2001","unstructured":"Sherman, M. Y. & Goldberg, A. L. Cellular defences against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron 29, 15\u201332 (2001).","journal-title":"Neuron"},{"key":"37935_CR72","doi-asserted-by":"publisher","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio, R. et al. \u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci. Transl. Med. 8, 342ra78, https:\/\/doi.org\/10.1126\/scitranslmed.aaf3634 (2016).","journal-title":"Sci. Transl. Med."},{"key":"37935_CR73","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/mds.10231","volume":"17","author":"J Winkelmann","year":"2002","unstructured":"Winkelmann, J., Stautner, A., Samtleban, W. & Trenkwalder, C. Long-term course of restless legs syndrome in uremic patients on hemodialysis patients after kidney transplantation. Mov. Disord. 17, 1072\u20131076 (2002).","journal-title":"Mov. Disord."},{"key":"37935_CR74","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0272-6386(03)00031-3","volume":"41","author":"J Takaki","year":"2003","unstructured":"Takaki, J. et al. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am. J. Kidney Dis. 41, 833\u2013839 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"37935_CR75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2006.01.028","volume":"399","author":"RM Freitas","year":"2006","unstructured":"Freitas, R. M., Sousa, F. C., Viana, G. S. & Fonteles, M. M. Acetylcholinesterase activities in hippocampus, frontal cortex and striatum of Wistar rats after pilocarpine-induced status epilepticus. Neurosci. Lett. 399, 76\u201378 (2006).","journal-title":"Neurosci. Lett."},{"key":"37935_CR76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp.74.1.113","volume":"74","author":"JO Rinne","year":"2003","unstructured":"Rinne, J. O. et al. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer\u2019s disease. J. Neurol. Neurosurg. Psychiatry 74, 113\u2013115 (2003).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"37935_CR77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5214\/ans.0972.7531.2008.150403","volume":"15","author":"A Tripathi","year":"2008","unstructured":"Tripathi, A. & Srivastava, U. C. Acetylcholinesterase: a Versatile Enzyme Of Nervous System. Annals Neurosci. 15, 106\u2013111 (2008).","journal-title":"Annals Neurosci."},{"key":"37935_CR78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.jrn.2007.10.025","volume":"18","author":"MJ Smogorzewski","year":"2008","unstructured":"Smogorzewski, M. J. & Massry, S. G. Altered acetylcholine in uremia: role metabolism of brain of secondary hyperparathyroidism. J. Renal Nutr. 18, 122\u2013126 (2008).","journal-title":"J. Renal Nutr."},{"key":"37935_CR79","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.neubiorev.2012.03.001","volume":"36","author":"L Nadel","year":"2012","unstructured":"Nadel, L., Hupbach, A., Gomez, R. & Newman-Smith, K. Memory formation, consolidation and transformation. Neurosci. Biobehav. Rev. 36, 1640\u20131645 (2012).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"37935_CR80","doi-asserted-by":"publisher","first-page":"e110482","DOI":"10.1371\/journal.pone.0110482","volume":"9","author":"D Kumar","year":"2014","unstructured":"Kumar, D. & Thakur, M. K. Perinatal Exposure to Bisphenol-A Impairs Spatial Memory through Upregulation of Neurexin1 and Neuroligin3 Expression in Male Mouse Brain. PLoS ONE 9, e110482, https:\/\/doi.org\/10.1371\/journal.pone.0110482 (2014).","journal-title":"PLoS ONE"},{"key":"37935_CR81","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/jpi.12076","volume":"55","author":"A Naskar","year":"2013","unstructured":"Naskar, A. et al. Melatonin synergizes with low doses of l-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism. J. Pineal Res. 55, 304\u201312 (2013).","journal-title":"J. Pineal Res."},{"key":"37935_CR82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroscience.2012.12.025","volume":"233","author":"BJ Morley","year":"2013","unstructured":"Morley, B. J. & Mervis, R. F. Dendritic spine alterations in the hippocampus and parietal cortex of alpha-7 nicotinic acetylcholine receptor knockout mice. Neuroscience 233, 54\u201363 (2013).","journal-title":"Neuroscience"},{"key":"37935_CR83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.yhbeh.2015.05.004","volume":"74","author":"M Frankfurt","year":"2015","unstructured":"Frankfurt, M. & Luine, V. The evolving role of dendritic spines and memory: interaction(s) with estradiol. Horm. Behav. 74, 28\u201336 (2015).","journal-title":"Horm. Behav."},{"key":"37935_CR84","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(96)12615-X","volume":"209","author":"JC Pan","year":"1996","unstructured":"Pan, J. C. et al. Epileptiform activity and hippocampal damage produced by intrahippocampal injection of guanidinosuccinic acid in rat. Neurosci. Letters 209, 121\u2013124 (1996).","journal-title":"Neurosci. Letters"},{"key":"37935_CR85","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/brain\/awf123","volume":"125","author":"MC Kiernan","year":"2002","unstructured":"Kiernan, M. C. et al. Nerve excitability changes in chronic renal failure indicate membrane depolarisation due to hyperkalemia. Brain 125, 1366\u20131378 (2002).","journal-title":"Brain"},{"key":"37935_CR86","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0272-6386(81)80011-X","volume":"1","author":"AL Babb","year":"1981","unstructured":"Babb, A. L., Ahmed, S., Bergstrom, J. & Scribner, B. H. The middle molecule hypothesis in perspective. Am. J. Kidney Dis. 1, 46\u201350 (1981).","journal-title":"Am. J. Kidney Dis."},{"key":"37935_CR87","first-page":"205","volume":"14","author":"R Vanholder","year":"1994","unstructured":"Vanholder, R., De Smet, R., Hsu, C., Vogeleere, P. & Ringoir, S. Uremic toxicity: the middle molecule hypothesis revisited. Sem. Nephrol. 14, 205\u2013218 (1994).","journal-title":"Sem. Nephrol."},{"key":"37935_CR88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000329097","volume":"34","author":"B Afsar","year":"2011","unstructured":"Afsar, B., Elsurer, R., Covic, A., Johanson, R. J. & Kanbay, M. Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am. J. Nephrol. 34, 49\u201354 (2011).","journal-title":"Am. J. Nephrol."},{"key":"37935_CR89","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00702-013-0989-x","volume":"120","author":"MN Wamser","year":"2013","unstructured":"Wamser, M. N. et al. Effect of hypoxanthine, antioxidants and Allopurinol on cholinesterase activities in rats. J. Neural Transm.(Vienna) 120, 1359\u20131367 (2013).","journal-title":"J. Neural Transm.(Vienna)"},{"key":"37935_CR90","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.1983.141","volume":"24","author":"CA Mahoney","year":"1983","unstructured":"Mahoney, C. A. & Arieff, A. I. Central and peripheral nervous system effects of chronic renal failure. Kidney Int. 24, 170\u2013177 (1983).","journal-title":"Kidney Int."},{"key":"37935_CR91","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1172\/JCI109064","volume":"61","author":"JD Cooper","year":"1978","unstructured":"Cooper, J. D., Lazarowitz, V. C. & Arieff, A. I. Neurodiagnostic abnormalities in patients with acute renal failure. J. Clin. Invest. 61, 1448\u20131455 (1978).","journal-title":"J. Clin. Invest."},{"key":"37935_CR92","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ki.1991.20","volume":"39","author":"JT Marsh","year":"1991","unstructured":"Marsh, J. T. et al. rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int. 39, 155\u2013163 (1991).","journal-title":"Kidney Int."},{"key":"37935_CR93","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/0886022X.2014.882240","volume":"36","author":"M Boban","year":"2014","unstructured":"Boban, M. et al. Circulating purine compounds, uric acid, and xanthine oxidase\/dehydrogenase relationship in essential hypertension and end stage renal disease. Ren. Fail. 36, 613\u2013618 (2014).","journal-title":"Ren. Fail."},{"key":"37935_CR94","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mehy.2017.12.016","volume":"111","author":"MK Mazumder","year":"2017","unstructured":"Mazumder, M. K., Phukan, B. C., Bhattacharjee, A. & Borah, A. Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment. Med. Hypotheses 111, 36\u201339 (2017).","journal-title":"Med. Hypotheses"},{"key":"37935_CR95","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.semnephrol.2005.06.012","volume":"26","author":"M Fabrazzo","year":"2006","unstructured":"Fabrazzo, M. & De Santo, R. M. Depression in chronic kidney disease. Semin. Nephrol. 26, 56\u201360 (2006).","journal-title":"Semin. Nephrol."},{"key":"37935_CR96","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1523\/JNEUROSCI.0178-05.2005","volume":"25","author":"MG Lee","year":"2005","unstructured":"Lee, M. G., Hassani, O. K., Alonso, A. & Jones, B. E. Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. J. Neurosci. 25, 4365\u20134369 (2005).","journal-title":"J. Neurosci."},{"key":"37935_CR97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1479-8425.2010.00465.x","volume":"9","author":"S Deurveilher","year":"2011","unstructured":"Deurveilher, S. & Semba, K. Basal forebrain regulation of cortical activity and sleep-wake states: Roles of cholinergic and non-cholinergic neurons. Sleep Biol. Rhythms 9, 65\u201370 (2011).","journal-title":"Sleep Biol. Rhythms"},{"key":"37935_CR98","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1159\/000488176","volume":"45","author":"Za\u2019abi,M Al","year":"2018","unstructured":"Al, Za\u2019abi,M. et al. Gum Acacia Improves Renal Function and Ameliorates Systemic Inflammation, Oxidative and Nitrosative Stress in Streptozotocin-Induced Diabetes in Rats with Adenine-Induced Chronic Kidney Disease. Cell Physiol. Biochem. 45, 2293\u20132304 (2018).","journal-title":"Cell Physiol. Biochem."},{"key":"37935_CR99","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nn.2741","volume":"14","author":"P Penzes","year":"2011","unstructured":"Penzes, P., Cahill, M. E., Jones, K. A., VenLeeuwen, J. E. & Woolfrey, K. M. Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285\u2013293 (2011).","journal-title":"Nat. Neurosci."},{"key":"37935_CR100","doi-asserted-by":"publisher","unstructured":"Qiao, H. et al. Dendritic spines in Depression: what we learned from animal models. Neural Plast. 8056370, https:\/\/doi.org\/10.1155\/2016\/8056370.","DOI":"10.1155\/2016\/8056370."},{"key":"37935_CR101","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2015.01.022","volume":"601","author":"CH Duman","year":"2015","unstructured":"Duman, C. H. & Duman, R. S. Spine synapse remodeling in the pathophysiology and treatment of depression. Neurosci. Lett. 601, 20\u201329 (2015).","journal-title":"Neurosci. Lett."},{"key":"37935_CR102","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/mp.2013.182","volume":"19","author":"A Lima","year":"2014","unstructured":"Lima, A. et al. Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats. Mol. Psychiatry 19, 834\u2013841 (2014).","journal-title":"Mol. Psychiatry"},{"key":"37935_CR103","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/glia.23143","volume":"65","author":"Q Wang","year":"2017","unstructured":"Wang, Q., Jie, W., Liu, J. H., Yang, J. M. & Gao, T. M. An astroglial basis of major depressive disorder? An overview. Glia 65, 1227\u20131250 (2017).","journal-title":"Glia"},{"key":"37935_CR104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15171\/jrip.2017.12","volume":"6","author":"NS Zahed","year":"2017","unstructured":"Zahed, N. S., Sharifi, M., Karimi, M. & Nikbakht, H. Impact of sertraline on serum concentration of CRP in hemodialysis patients with depression. J. Renal Inj. Prev. 6, 65\u201369 (2017).","journal-title":"J. Renal Inj. Prev."},{"key":"37935_CR105","doi-asserted-by":"crossref","first-page":"c115","DOI":"10.1159\/000089669","volume":"102","author":"B Kalender","year":"2006","unstructured":"Kalender, B., Ozdemir, A. C. & Koroglu, G. Association of Depression with Markers of Nutrition and Inflammation in Chronic Kidney Disease and End-Stage Renal Disease. Nephron Clin. Pract. 102, c115\u2013c121 (2006).","journal-title":"Nephron Clin. Pract."},{"key":"37935_CR106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/187152707780619326","volume":"6","author":"G Rajkowska","year":"2007","unstructured":"Rajkowska, G. & Miguel-Hidalgo, J. J. Gliogenesis and Glial Pathology in Depression. CNS Neurol. Disord. Drug Targets 6, 219\u2013233 (2007).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"37935_CR107","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s11255-018-1891-0","volume":"50","author":"G Gerogianni","year":"2018","unstructured":"Gerogianni, G., Kouzoupis, A. & Grapsa, E. A holistic approach to factors affecting depression in haemodialysis patients. Int. Urol. Nephrol. 50, 1467\u20131476 (2018).","journal-title":"Int. Urol. Nephrol."},{"key":"37935_CR108","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/13548506.2018.1469779","volume":"23","author":"F Teles","year":"2018","unstructured":"Teles, F., de Albuquerque, A. L. A., Lins, I. K. F. G., Medrado, P. C. & Costa, A. F. P. Quality of life and depression in haemodialysis patients. Psychol. Health Med. 23, 1069\u20131078 (2018).","journal-title":"Psychol. Health Med."},{"key":"37935_CR109","doi-asserted-by":"publisher","first-page":"e0171009","DOI":"10.1371\/journal.pone.0171009","volume":"12","author":"JH Jhee","year":"2017","unstructured":"Jhee, J. H. et al. Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. PLoS ONE 12, e0171009, https:\/\/doi.org\/10.1371\/journal.pone.0171009 (2017).","journal-title":"PLoS ONE"},{"key":"37935_CR110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0009-8981(87)90088-X","volume":"167","author":"PP De Deyn","year":"1987","unstructured":"De Deyn, P. P. et al. Guanidino compounds in serum and cerebrospinal fluid of non-dialysed patients with renal insufficiency. Clin. Chim. Acta. 167, 81\u201388 (1987).","journal-title":"Clin. Chim. Acta."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37935-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T06:26:04Z","timestamp":1721024764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37935-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37935"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37935-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"17 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3097"}}